Ganglioside Alters Phospholipase Trafficking, Inhibits NF-κB Assembly, and Protects Tight Junction Integrity.

Area of Science:

• Gastroenterology
• Immunology
• Cell Biology

Background:

• Dietary gangliosides are present in human milk and organ meats.
• Clinical and animal studies suggest gangliosides can reduce inflammatory signaling pathways implicated in inflammatory bowel disease (IBD).
• Gangliosides have demonstrated the ability to decrease pro-inflammatory markers, enhance intestinal permeability, and alleviate IBD symptoms.

Purpose of the Study:

• To investigate the specific mechanisms through which dietary gangliosides exert beneficial effects on intestinal health.
• To elucidate how gangliosides impact inflammatory processes and barrier function in the gut.

Main Methods:

• In vitro studies utilized CaCo-2 intestinal epithelial cells.
• Gangliosides were extracted from milk powder and applied to differentiated cells exposed to pro-inflammatory stimuli.
• Assays included electron microscopy for gut barrier integrity, transepithelial electric resistance for epithelial barrier function, and ELISA for HBD-2, IL-23, NF-κB, and sPLA2.

Main Results:

• Gangliosides significantly attenuated the disruption of tight junctions caused by inflammatory stimuli, thereby improving epithelial barrier function (P < 0.05).
• Gangliosides reduced the basolateral secretion of sPLA2 (P ≤ 0.05), decreased levels of HBD-2 and IL-23 (P ≤ 0.05), and inhibited NF-κB activation (P ≤ 0.05).

Conclusions:

• Ganglioside GD3 enhances intestinal integrity by modulating sPLA2 trafficking.
• Pro-inflammatory mediator production is reduced through decreased NF-κB complex assembly.
• Dietary gangliosides present a promising therapeutic strategy for IBD, evidenced by their ability to reduce inflammatory signaling and improve intestinal barrier function in vitro.